AIM ImmunoTech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AIM ImmunoTech and other ETFs, options, and stocks.

About AIM

AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. 

CEO
Thomas Kenwood Equels
CEOThomas Kenwood Equels
Employees
19
Employees19
Headquarters
Ocala, Florida
HeadquartersOcala, Florida
Founded
1966
Founded1966
Employees
19
Employees19

AIM Key Statistics

Market cap
4.09M
Market cap4.09M
Price-Earnings ratio
-0.04
Price-Earnings ratio-0.04
Dividend yield
Dividend yield
Average volume
133.90K
Average volume133.90K
High today
$0.507
High today$0.507
Low today
$0.50
Low today$0.50
Open price
$0.507
Open price$0.507
Volume
58.23K
Volume58.23K
52 Week high
$20.35
52 Week high$20.35
52 Week low
$0.475
52 Week low$0.475

Stock Snapshot

AIM ImmunoTech(AIM) stock is priced at $0.50, giving the company a market capitalization of 4.09M. It carries a P/E multiple of -0.04.

On 2026-05-06, AIM ImmunoTech(AIM) stock traded between a low of $0.50 and a high of $0.51. Shares are currently priced at $0.50, which is +0.4% above the low and -1.0% below the high.

The AIM ImmunoTech(AIM)'s current trading volume is 58.23K, compared to an average daily volume of 133.9K.

During the past year, AIM ImmunoTech(AIM) stock moved between $0.48 at its lowest and $20.35 at its peak.

During the past year, AIM ImmunoTech(AIM) stock moved between $0.48 at its lowest and $20.35 at its peak.

People also own

Based on the portfolios of people who own AIM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.